Gigtforeningen: Bopæl afgør behandlingen

Ny undersøgelse foretaget af TNS Gallup for Gigtforeningen.

By Redaktionen

March 4, 2015 5:00 AM

Rygpatienter bliver behandlet vidt forskelligt afhængig af hvilken kommune, de bor i.

Det dokumenterer en helt ny undersøgelse foretaget af TNS Gallup for Gigtforeningen. Forskelsbehandlinger sker på trods af, at alle fem regioner har lavet et gedigent rygprogram, der fortæller alt om den behandling, man skal have også i kommunerne, siger direktør i Gigtforeningen, Lene Witte:

1 month free trial

Get access to all content on Life Science Nordic

No commitment or card information required

Try Life Science Nordic now

Already a subscriber? Log In

Applies to personal subscription only.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.

Yes please, I would like to receive Life Science Nordics newsletter Read cookie and data policy.

Yes please, I would like to receive marketing, offers, surveys, etc. from Life Science Nordic Read cookie and data policy.

{{ window.visitor.corporateClient.name }}

Corporate solution

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}

Gigtforeningen: Bopæl afgør behandlingen

LEO Pharma acquires dermatology drug for 435 million USD

Trump expected to pick Heidi Overton to lead the FDA

Pila Pharma cleared to begin obesity trial

Life sciences fuel Greater Copenhagen's economic growth

Sanofi cuts 229 jobs following $9.1bn acquisition

Evaxion drops solid tumour vaccine to advance new glioblastoma program

OCTONIQ, Ett smart, modulärt CIP-system.

ZEISS Innovation Summit returns to Berlin

Ensuring Safety and Compliance for IVD Products

100 000 timmar av beprövad tillförlitlighet: KNF:s membranpumpar sätter en ny standard

60 års expertis inom läcksökning: Pfeiffer Vacuum+Fab Solutions firar ett jubileum

From Complex Biology to Faster Decisions: Scalable 3D HCA for NAM-Driven Drug Discovery

QAdvis & Scandinavian CRO are now Aurevia

Experience fast and easy optical inspection

Strengthen your team with Clinical and Regulatory Experts

Clinical and regulatory expertise that delivers results

Medtech Compliance Forum by Aurevia & RAPS

Experienced clinical and regulatory support for a busy autumn